Secura Bio, Inc. ( an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today ...
Cash balance of $344.8 million as of September 30, 2025, together with net proceeds of ~$445 million from October 2025 equity offering, with expected runway into 2028 BEDFORD, Mass., Nov. 04, 2025 ...
US consumer health company Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for ...
According to the latest analysis by DataM Intelligence, the Next-Generation Multiple Myeloma Therapies Market Size was valued ...
In reviewing the current state of evidence, several points stand out. The strongest findings show that low doses of ketamine ...
Comparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth maintained, in contrast to growth suppression ...
Novo Nordisk NVO is scheduled to report its third-quarter 2025 results before the opening bell on Nov. 5, 2025. The Zacks ...
A global analysis of 125 turmeric supplements across five major markets revealed widespread inconsistencies in labeling, ...
A malaria test commonly used across Asia and South America “is not fit for purpose”, researchers have claimed.
Findings further demonstrate the effectiveness of Roche's approved medicines in advancing treatment standards for people with blood disorders Data from innovative pipeline signals progress ...
The chronic progressive multiple sclerosis market size is anticipated to grow during the forecast period (2025–2034).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback